标题
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis
作者
关键词
-
出版物
ANNALS OF NEUROLOGY
Volume 69, Issue 5, Pages 759-777
出版商
Wiley
发表日期
2011-03-22
DOI
10.1002/ana.22426
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients
- (2010) Trina A. Johnson et al. CLINICAL IMMUNOLOGY
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
- (2010) M. Mehling et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature
- (2010) J. Chun et al. PHARMACOLOGICAL REVIEWS
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotection and neuroregeneration in multiple sclerosis
- (2009) Martin Stangel JOURNAL OF NEUROLOGY
- FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses
- (2009) Dimitrios Papadopoulos et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
- (2009) Florian Mullershausen et al. Nature Chemical Biology
- Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
- (2009) David Marsolais et al. NATURE REVIEWS DRUG DISCOVERY
- Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions
- (2009) Peter Vogel et al. PLoS One
- Treatment with Immunosuppressants FTY720 and Tacrolimus Promotes Functional Recovery after Spinal Cord Injury in Rats
- (2009) Jie Zhang et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to Fingolimod
- (2008) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- Astrocytes in multiple sclerosis: A product of their environment
- (2008) A. Nair et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease
- (2008) Yun-Ping Wu et al. HUMAN MOLECULAR GENETICS
- Central nervous system-directed effects of FTY720 (fingolimod)
- (2008) Veronique E. Miron et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
- FTY720 modulates human oligodendrocyte progenitor process extension and survival
- (2007) Veronique E. Miron et al. ANNALS OF NEUROLOGY
- Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
- (2007) Kumlesh K. Dev et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started